Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Gigaxonin ELISA Kit (AC3808)
Cat.#: ASET-2397
Specifications
Description Human Gigaxonin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Gigaxonin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.35 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2143 Human Ephrin A3 ELISA Kit (AC3554) Quantitative inquiry ASET-1229 Rat Calretinin ELISA Kit (AC2640) Quantitative inquiry ASET-1183 Human ZnT1 ELISA Kit (AC2594) Quantitative inquiry ASET-1673 Mouse NKCC1 ELISA Kit (AC3084) Quantitative inquiry ASET-1363 Rat ACTH ELISA Kit (AC2774) Quantitative inquiry ASET-2255 Mouse Semaphorin 7a ELISA Kit (AC3666) Quantitative inquiry ASET-1021 Mouse FADS2 ELISA Kit (AC2432) Quantitative inquiry ASET-2282 Rat Nogo ELISA Kit (AC3693) Quantitative inquiry ASET-2537 Human Neurofilament Heavy Polypeptide ELISA Kit (AC3948) Quantitative inquiry ASET-1115 Human AVPR1B ELISA Kit (AC2526) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket